D.L. Taylor

976 total citations
20 papers, 572 citations indexed

About

D.L. Taylor is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, D.L. Taylor has authored 20 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 11 papers in Virology and 11 papers in Epidemiology. Recurrent topics in D.L. Taylor's work include HIV Research and Treatment (11 papers), HIV/AIDS drug development and treatment (11 papers) and Cytomegalovirus and herpesvirus research (10 papers). D.L. Taylor is often cited by papers focused on HIV Research and Treatment (11 papers), HIV/AIDS drug development and treatment (11 papers) and Cytomegalovirus and herpesvirus research (10 papers). D.L. Taylor collaborates with scholars based in United Kingdom, United States and Japan. D.L. Taylor's co-authors include A.S. Tyms, Jacqueline M. Golding, Philip Stanier, Alan D. Kitchen, Jacqueline Parkin, M.S. Kang, Yvonne Tryhorn, Robert J. Nash, Linda E. Fellows and C G Bridges and has published in prestigious journals such as Journal of Biological Chemistry, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

D.L. Taylor

20 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.L. Taylor United Kingdom 12 223 131 124 112 111 20 572
Michiko Tanaka Japan 15 458 2.1× 43 0.3× 65 0.5× 67 0.6× 237 2.1× 47 1.1k
Makoah N. Aminake Germany 13 103 0.5× 251 1.9× 112 0.9× 45 0.4× 283 2.5× 19 834
J. P. Séguéla France 13 260 1.2× 119 0.9× 106 0.9× 56 0.5× 218 2.0× 51 805
Tania Silva Portugal 14 80 0.4× 72 0.5× 37 0.3× 38 0.3× 148 1.3× 36 506
Lin Gan China 15 169 0.8× 296 2.3× 18 0.1× 28 0.3× 156 1.4× 56 799
K Jayashree India 11 165 0.7× 112 0.9× 48 0.4× 11 0.1× 110 1.0× 39 557
Eddy Ríos‐Olivares Puerto Rico 13 95 0.4× 82 0.6× 25 0.2× 56 0.5× 63 0.6× 35 361
Yu. S. Boriskin United Kingdom 11 288 1.3× 275 2.1× 61 0.5× 32 0.3× 101 0.9× 25 618
Jean Bernatchez United States 14 192 0.9× 201 1.5× 101 0.8× 54 0.5× 287 2.6× 46 713
Carmen Lau United States 9 124 0.6× 68 0.5× 23 0.2× 19 0.2× 79 0.7× 22 311

Countries citing papers authored by D.L. Taylor

Since Specialization
Citations

This map shows the geographic impact of D.L. Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.L. Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.L. Taylor more than expected).

Fields of papers citing papers by D.L. Taylor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.L. Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.L. Taylor. The network helps show where D.L. Taylor may publish in the future.

Co-authorship network of co-authors of D.L. Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of D.L. Taylor. A scholar is included among the top collaborators of D.L. Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.L. Taylor. D.L. Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gu, Zhengxian, Brigitte Allard, Jennifer L. Lippens, et al.. (2006). In Vitro Antiretroviral Activity and In Vitro Toxicity Profile of SPD754, a New Deoxycytidine Nucleoside Reverse Transcriptase Inhibitor for Treatment of Human Immunodeficiency Virus Infection. Antimicrobial Agents and Chemotherapy. 50(2). 625–631. 34 indexed citations
2.
Golding, Jacqueline M., et al.. (2000). Prevalence of sexual abuse history in a sample of women seeking treatment for premenstrual syndrome. Journal of Psychosomatic Obstetrics & Gynecology. 21(2). 69–80. 94 indexed citations
3.
Taylor, D.L., Paul J. Chambers, A.S. Tyms, et al.. (1999). Pyrido [1,2a] Indole Derivatives Identified as Novel Nonnucleoside Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Type 1. Antiviral chemistry & chemotherapy. 10(2). 79–86. 27 indexed citations
4.
Heguy, Adriana, David W. Houck, Silvia Russo, et al.. (1998). Isolation and Characterization of the Fungal Metabolite 3-O-Methylviridicatin as an Inhibitor of Tumour Necrosis Factor α-Induced Human Immunodeficiency Virus Replication. Antiviral chemistry & chemotherapy. 9(2). 149–155. 40 indexed citations
5.
Taylor, D.L., et al.. (1996). Anti-HIV Activity of MDL 74968, a Novel Acyclonucleotide Derivative of Guanine: Drug Resistance and Drug Combination Effects in Vitro. Antiviral chemistry & chemotherapy. 7(5). 253–260. 3 indexed citations
6.
Bridges, C G, et al.. (1996). MDL 74,968, a new acyclonucleotide analog: activity against human immunodeficiency virus in vitro and in the hu-PBL-SCID.beige mouse model of infection. Antimicrobial Agents and Chemotherapy. 40(5). 1072–1077. 5 indexed citations
7.
8.
Taylor, D.L., et al.. (1995). Basis of Relative Insensitivity of HIV-Infected JM Cells to AZT. Antiviral chemistry & chemotherapy. 6(5). 307–311. 3 indexed citations
9.
10.
Dorsselaer, V. Van, Daniel Schirlin, Céline Tarnus, et al.. (1994). Increased antiviral activity of HIV protease inhibitors of the difluorostatone type bearing (R)-valinol derivatives as novel c-termini. Bioorganic & Medicinal Chemistry Letters. 4(10). 1213–1218. 4 indexed citations
11.
Stanier, Philip, Alan D. Kitchen, D.L. Taylor, & A.S. Tyms. (1992). Detection of human cytomegalovirus in peripheral mononuclear cells and urine samples using PCR. Molecular and Cellular Probes. 6(1). 51–58. 23 indexed citations
12.
Taylor, D.L., Robert J. Nash, Linda E. Fellows, M.S. Kang, & A.S. Tyms. (1992). Naturally Occurring Pyrrolizidines: Inhibition of α-Glucosidase 1 and Anti-HIV Activity of One Stereoisomer. Antiviral chemistry & chemotherapy. 3(5). 273–277. 49 indexed citations
13.
Cardin, A D, Peter L. Smith, Dale T. Blankenship, et al.. (1991). Stilbene disulfonic acids. CD4 antagonists that block human immunodeficiency virus type-1 growth at multiple stages of the virus life cycle. Journal of Biological Chemistry. 266(20). 13355–13363. 22 indexed citations
14.
Cardin, A D, Peter L. Smith, Dale T. Blankenship, et al.. (1991). Stilbene disulfonic acids: CD4 antagonists that block human immunodeficiency virus type-1 growth at multiple stages of the virus life cycle. Antiviral Research. 15. 125–125. 2 indexed citations
15.
Stanier, Philip, et al.. (1989). Persistence of cytomegalovirus in mononuclear cells in peripheral blood from blood donors.. BMJ. 299(6704). 897–898. 103 indexed citations
16.
Tyms, A.S., D.L. Taylor, & Jacqueline Parkin. (1989). Cytomegalovirus and the acquired immunodeficiency syndrome. Journal of Antimicrobial Chemotherapy. 23(suppl A). 89–105. 52 indexed citations
17.
Taylor, D.L., David Taylor‐Robinson, David Jeffries, & A.S. Tyms. (1988). Characterization of cytomegalovirus isolates from patients with AIDS by DNA restriction analysis. Epidemiology and Infection. 101(3). 483–494. 6 indexed citations
18.
Taylor, D.L., Linda E. Fellows, Graham H. Farrar, et al.. (1988). Loss of cytomegalovirus infectivity after treatment with castanospermine or related plant alkaloids correlates with aberrant glycoprotein synthesis. Antiviral Research. 10(1-3). 11–26. 34 indexed citations
19.
Taylor, D.L., D J Jeffries, David Taylor‐Robinson, Jacqueline Parkin, & A.S. Tyms. (1988). The susceptibility of adenovirus infection to the anti-cytomegalovirus drug, ganciclovir (DHPG). FEMS Microbiology Letters. 49(3). 337–341. 18 indexed citations
20.
Davis, Jennifer, N B La Thangue, D.L. Taylor, et al.. (1988). Cellular polypeptides overexpressed after herpes simplex infection permit virus subtyping and may help diagnose cervical cancer.. Sexually Transmitted Infections. 64(5). 321–326. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michiko Tanaka Breakdown of academic impact, for papers by Makoah N. Aminake Breakdown of academic impact, for papers by J. P. Séguéla Breakdown of academic impact, for papers by Tania Silva Breakdown of academic impact, for papers by Lin Gan Breakdown of academic impact, for papers by K Jayashree Breakdown of academic impact, for papers by Eddy Ríos‐Olivares Breakdown of academic impact, for papers by Yu. S. Boriskin Breakdown of academic impact, for papers by Jean Bernatchez Breakdown of academic impact, for papers by Carmen Lau
Rankless by CCL
2026